StockWatch
·

Eris Lifesciences Ltd Q4 FY26 Results

ERISQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue756.566.3%7.3%
Total Income758.796.0%6.4%
Expenditure598.187.3%2.4%
PBT160.6110.6%24.7%
Net Profit279.10156.5%172.7%
OPM36.16%3.42pp0.38pp
NPM36.78%23.30pp22.43pp
EPS20.60181.4%198.6%
View full financials

Informational and educational content only. Not investment advice.